Michael Brooks
Präsident bei EDESA BIOTECH, INC.
Vermögen: 78 945 $ am 30.04.2024
Aktive Positionen von Michael Brooks
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
EDESA BIOTECH, INC. | Präsident | 07.06.2019 | - |
Corporate Officer/Principal | 01.09.2015 | 01.01.2019 |
Karriereverlauf von Michael Brooks
Ehemalige bekannte Positionen von Michael Brooks
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CIPHER PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.01.2010 | 01.01.2015 |
Edesa Biotech Research, Inc. | Corporate Officer/Principal | 01.01.2015 | - |
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Präsident | 01.01.2015 | - |
Ausbildung von Michael Brooks
University of Toronto | Doctorate Degree |
Rotman School of Management | Masters Business Admin |
Statistik
International
Kanada | 7 |
Operativ
Corporate Officer/Principal | 3 |
President | 2 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
EDESA BIOTECH, INC. | Health Technology |
CIPHER PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Edesa Biotech, Inc. (Old)
Edesa Biotech, Inc. (Old) Pharmaceuticals: MajorHealth Technology Edesa Biotech, Inc. engages in the development of treatments for dermatological and anorectal diseases. Its product pipeline is based on non-steroidal molecules for the treatment of allergic contact dermatitis, hemorrhoids, and anal fissures. The company was founded by Par Nijhawan in 2015 and is headquartered in Markham, Canada. | Health Technology |
Edesa Biotech Research, Inc. |
- Börse
- Insiders
- Michael Brooks
- Erfahrung